Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Pediatric Endocrinology
Published in: International Journal of Pediatric Endocrinology 1/2012

Open Access 01-12-2012 | Letter to the Editor

Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes

Authors: Franziska K Bishop, R Paul Wadwa, Sam Ellis, Marian Rewers, David M Maahs

Published in: International Journal of Pediatric Endocrinology | Issue 1/2012

Login to get access

Abstract

Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
Maahs DM, Wadwa RP, Bishop F, Daniels SR, Rewers M, Klingensmith GJ: Dyslipidemia in youth with diabetes: to treat or not to treat?. J Pediatr. 2008, 153: 458-465. 10.1016/j.jpeds.2008.05.062.PubMedCentralCrossRefPubMed
2.
Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ: Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The search for diabetes in youth study. J Pediatr. 2006, 149: 314-319. 10.1016/j.jpeds.2006.04.065.CrossRefPubMed
3.
Haller MJ, Stein JM, Shuster JJ, Theriaque D, Samyn MM, Pepine C: Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2009, 22: 65-68.PubMedCentralCrossRefPubMed
4.
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr. 2009, 9: 79-
Metadata
Title
Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
Authors
Franziska K Bishop
R Paul Wadwa
Sam Ellis
Marian Rewers
David M Maahs
Publication date
01-12-2012
Publisher
BioMed Central
Published in
International Journal of Pediatric Endocrinology / Issue 1/2012
Electronic ISSN: 1687-9856
DOI
https://doi.org/10.1186/1687-9856-2012-24

Other articles of this Issue 1/2012

International Journal of Pediatric Endocrinology 1/2012 Go to the issue

Research

A single sample GnRHa stimulation test in the diagnosis of precocious puberty

Research

Long-term effects of a non-intensive weight program on body mass index and metabolic abnormalities of obese children and adolescents

Research

Weight loss on stimulant medication: how does it affect body composition and bone metabolism? – A prospective longitudinal study

Research

Urinary gonadotrophins: a useful non-invasive marker of activation of the hypothalamic pituitary-gonadal axis

Research

Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observational studies

Research

Impaired endothelial function in pediatric patients with turner syndrome and healthy controls: a case-control study